12-1-2-2　ⓔ文献

  1. 日本肝臓学会編：肝癌診療ガイドライン2017年版 補訂版，金原出版，2020．

  2. Castéra L, Vergniol J, et al: Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology, 2005; 128: 343–350.

  3. Shiina T, Nightingale KR, et al: WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part1. basic principles and terminology. Ultrasound Med Biol, 2015; 41: 1126–1147.

  4. Eddowes PJ, Sasso M, et al: Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology, 2019; 156: 1717–1730.

  5. Caussy C, Alquiraish MH, et al: Optimal threshold of controlled attenuation parameter with MRI–PDFF as the gold standard for the detection of hepatic steatosis. Hepatology, 2018; 67: 1348–1359.

  6. Tsujimoto F, Abe T, et al: Temporal changes in internal echoes in hepatic hemangiomas. Jpn J radiol, 1989; 49: 574–582.

  7. 大竹宏治，朝井　均，他：体位変換による肝血管腫の超音波像の変化 ("Chameleon"Sign) についての検討．日本画像医学雑誌，1991; 10: 120–125.

  8. 飯島尋子，肥塚明日香，他：肝血管腫にみられるスペックルのゆらぎ"fluttering signal"について．超音波医学，2000; 27: 457.

  9. 竹内和男：肝血管腫の超音波像拡大及びdynamic imageによる観察．日本超音波医学会研究発表会講演論文集，1984; 44: 319–320.

  10. Dietrich C, Mertens J, et al: Contrast–enhanced ultrasound of histologically proven liver hemangiomas. Hepatology, 2007; 45: 1139–1145.

  11. Attal P, Vilgrain V, et al: Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology, 2003; 228: 465–472.

  12. Dietrich C, Schuessler G, et al: Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast–enhanced ultrasound. Br J Radiol, 2005; 78: 704–707.

  13. Zhu Z, Yang L, et al: Myomatous hepatic angiomyolipoma: imaging findings in 14 cases with radiological–pathological correlation and review of the literature Br J Radiol, 2014; 87: 20130712.